Representatives of the Academy of Science of Czech Republic and Charles University have subscribed to the Founding Contract of the Biotechnological and Biomedical Center (BIOCEV) that will be situated in the vicinity of Vestec. and Luděk Svoboda.
The Academy of Sciences of the Czech Republic (AS CR) established a new public research institution, the Institute of Biotechnology AS CR, v. v. i. The primary ambition of this new institute is to develop cutting-edge basic and oriented research on topics opening for diagnostic and therapeutic applicatons in human medicine. In particular, the institute was established to serve as a nucleation center of BIOCEV, the joined Biotech & Biomed Research Center of the Academy of Sciences with Charles University, to be built at Vestec near Prague by the year 2012 with the support of the European Regional Development Funds in frame of the Operational Program R&D for Innovation., Peter Šebo, -red-., and Tři otázky pro ředitele připravila -red-
In the presence of Deputy Minister of Education, Youth and Sports, Stanislav Štech, Rector of Charles University Tomáš Zima, Vice-President of the Academy of Sciences of the Czech Republic, Vladimír Mareček, and other important guests, the implementation phase of the BIOCEV project - the Biotechnology and Biomedicine Centre of the Academy of Sciences of the Czech Republic and Charles University in Vestec was concluded on December 18, 2015. Full operation is beginning in January 2016. BIOCEV currently implements five research programmes and consists of six sets of research infrastructure and service laboratories. By 2020, as many as 450 researchers, including 200 post-graduate students, are supposed to work at the BIOCEV Centre. The Centre´s objective is to leam details about organisms at the molecular level that can be used in applied research and in the development of new therapeutic procedures. and Marina Hužvárová.